Research Topics
| Yu ShenSummaryAffiliation: The University of Texas Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancerYu Shen
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4095, USA
J Natl Cancer Inst 100:1448-53. 2008..Its effect on the time to first diagnosis of breast cancer has not been reported. We used information from the randomized, placebo-controlled Breast Cancer Prevention Trial (BCPT) to make that evaluation...
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004Yu Shen
Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 115:2041-51. 2009..D. Anderson Cancer Center (MDACC)...
A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinationsYu Shen
Department of Biostatistics and Applied Mathematics, M D Anderson Cancer Center University of Texas, 1515 Holcombe Boulevard, Box 447, Houston, TX 77030, USA
Cancer Epidemiol Biomarkers Prev 14:529-32. 2005..Annual mammography combined with CBE every 6 months will lead to a 41% increase in the quality-adjusted life years compared with annual mammography and CBE from 50 to 79, whereas the total cost increases by 30%...
Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distributionYu Shen
Department of Biostatistics and Applied Mathematics, M D Anderson Cancer Center, University of Texas, Houston, TX 77030, USA
Biostatistics 6:604-14. 2005..The different estimation methods provide complimentary tools to obtain the unknown parameters. The methods are applied to three breast cancer early-detection trials...
Adaptive design: estimation and inference with censored data in a semiparametric modelYu Shen
Department of Biostatistics, M D Anderson Cancer Center, Houston, TX 77030, USA
Biostatistics 8:306-22. 2007..Extensive simulation studies show that the asymptotic confidence intervals have reasonable nominal probability of coverage, and the proposed point estimators are nearly unbiased with practical sample sizes...
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?Yu Shen
Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 447, Houston, TX 77030, USA
Breast Cancer Res Treat 102:347-56. 2007..To determine the influence of race on breast cancer treatment and on recurrence and breast cancer specific death...
Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trialYu Shen
Department of Biostatistics and Applied Mathematics, MD Anderson Cancer Center, University of Texas, Houston, 77030, USA
Biometrics 61:992-9. 2005..We illustrate the methodology using data from a randomized breast cancer screening trial...
Role of detection method in predicting breast cancer survival: analysis of randomized screening trialsYu Shen
Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Natl Cancer Inst 97:1195-203. 2005..Method of detection appears to be an important prognostic factor, even after adjusting for known tumor characteristics. This finding suggests that clinical trialists should routinely collect information about method of detection...
Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experienceWenli Dong
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Cancer Epidemiol Biomarkers Prev 17:1096-103. 2008..To assess the effect of tumor detection method (screening versus symptom-based diagnosis) in predicting breast cancer survival and investigate how biological features of breast cancer are related to the tumor detection method...
Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring SystemMiloslav Beran
Department of Leukemia, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
Leuk Lymphoma 48:1150-60. 2007....
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma
Department of Genitourinary Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Proc Natl Acad Sci U S A 104:3967-72. 2007..001) and overall survival (P = 0.018) than did patients with similar-staged UC and fewer intratumoral CD8 TILs. We conclude that the extent of intratumoral CD8 TILs is an important prognostic indicator in advanced UC...
Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelinesCharlotte Hsieh Ahern
Department of Medicine, The Dan L Duncan Cancer Center at Baylor College of Medicine, Houston, TX 77030 4009, USA
Cancer Epidemiol Biomarkers Prev 18:718-25. 2009..We considered costs of screening examinations, subsequent work-up, biopsy, and treatment interventions after diagnosis...
Surveillance for recurrent bladder cancer using a point-of-care proteomic assayH Barton Grossman
Department of Urology, M. D. Anderson Cancer Center, Houston, Tex 77030, USA
JAMA 295:299-305. 2006..2%; 95% CI, 87.7%-97.8%; P = .08). CONCLUSION: The noninvasive point-of-care assay for elevated urinary NMP22 protein can increase the ability to detect recurrent bladder cancer, with test results available during the patient visit...
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerJohn W Davis
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Eur Urol 55:1135-43. 2009..Nonrandomized studies of unilateral nerve-sparing (UNS) radical prostatectomy (RP) have reported improved recovery of erectile function if the sacrificed cavernous nerve is reconstructed with a sural nerve graft (SNG)...
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromesQinglong Hu
Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Cancer 100:1884-91. 2004..They may play a role in the pharmacodynamics of therapeutic agents that are supposed to bind directly to these receptors...
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcomeAnne S Tsao
MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, P.O. Box 428 Houston, TX 77030, USA
Leuk Res 28:373-8. 2004..However, after accounting for these covariates, multivariate analysis indicates that higher c-kit expression predicts higher CR rates, although there was no effect on DFS in CR...
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke
Center for Genitourinary Oncology, and Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
J Urol 172:481-4. 2004..Neuroendocrine tumors of the bladder comprise a small subset of all bladder tumors. To improve our understanding of this tumor and define outcomes with current management, we performed a retrospective review of these cases...
Adaptive design and estimation in randomized clinical trials with correlated observationsGuosheng Yin
Department of Biostatistics and Applied Mathematics, M D Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA
Biometrics 61:362-9. 2005..Estimation of the parameter of interest and its confidence interval are proposed. We conduct simulation studies to examine the operating characteristics and illustrate the proposed method with an example...
Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668Darren W Davis
Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 11:678-89. 2005..CONCLUSIONS: SU5416 and SU6668 displayed biological activity in xenografts. However, neither drug produced marked biological activity in primary patient tumors...
Prognostic significance of monocytosis in patients with myeloproliferative disordersMiloslav Beran
Departments of Leukemia, UT MD Anderson Cancer Center, PO Box 301402, Houston, TX 77230, USA
Leuk Lymphoma 47:417-23. 2006..The diagnosis of CMML is prognostically significant and independently associated with a shorter survival and a higher risk of death than BCR/ABL-negative CML or Ph(1-) BCR/ABL-unknown CML...
The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivoAshish M Kamat
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Mol Cancer Ther 3:279-90. 2004..Together, our results demonstrate that bortezomib has significant antiproliferative activity in aggressive bladder cancer cells, which is best exploited within the context of combination chemotherapy...
Myelodysplastic syndrome is not merely "preleukemia"Maher Albitar
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston 77030 4095, USA
Blood 100:791-8. 2002....
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis
Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Urology 73:337-41. 2009..To evaluate the effect of adjuvant thalidomide on recurrence-free survival (RFS) after nephrectomy for high-risk metastatic renal cell carcinoma (RCC)...
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experienceArlene O Siefker-Radtke
Center for Genitourinary Oncology, Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, USA
J Urol 169:1295-8. 2003..Chemotherapy appropriate for enteric type adenocarcinoma can induce objective responses but meaningful improvement in survival is not yet demonstrated...
A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trialB Nebiyou Bekele
Department of Biostatistics and Applied Mathematics, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Biometrics 61:343-54. 2005..Extensive simulation studies show that the design reliably chooses the preferred dose using both toxicity and expression outcomes under various clinical scenarios...
Symptomatic local recurrence of prostate carcinoma after radiation therapyDan Leibovici
Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:2060-6. 2005..Aggressive histologic subtypes were predictive of this endpoint. Clinical T classification, Gleason score, and initial prostate-specific antigen levels also may have predictive value...
Self-designing trial combined with classical group sequential monitoringGuosheng Yin
Department of Biostatistics and Applied Mathematics, M D Anderson Cancer Center, The University of Texas, Houston, Texas, USA
J Biopharm Stat 15:667-75. 2005..The futility stopping rule allows the trial to be terminated when there is no beneficial treatment effect. We conduct simulation studies to evaluate the performance of the proposed design...
Estimation of age-specific sensitivity and sojourn time in breast cancer screening studiesXiuyu J Cong
Department of Statistics, Rice University, Houston, TX 77005, USA
Stat Med 24:3123-38. 2005..The proposed methods are illustrated using data from two large breast cancer screening trials. The results show that the screening sensitivity increases with age at screening examinations based on these two trials...
Monitoring late-onset toxicities in phase I trials using predicted risksB Nebiyou Bekele
Department of Biostatistics, MD Anderson Cancer Center, Houston, TX 77030, USA
Biostatistics 9:442-57. 2008..This advantage increases with accrual rate, but the price of this additional safety is that the trial takes longer to complete on average...
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndromeGloria N Mattiuzzi
Department of Leukemia, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 97:450-6. 2003..The authors evaluated the efficacy and toxicity of liposomal amphotericin B (L-AmB) compared with a combination of fluconazole plus itraconazole (F+I) as prophylaxis in this setting...
p63 expression defines a lethal subset of muscle-invasive bladder cancersWoonyoung Choi
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
PLoS ONE 7:e30206. 2012..Previous studies demonstrated that p63 is downregulated in muscle-invasive bladder cancers, but the relationship between p63 expression and survival is not clear...
Buckley-James-type estimator with right-censored and length-biased dataJing Ning
Division of Biostatistics, The University of Texas School of Public Health, Houston, Texas 77030, USA
Biometrics 67:1369-78. 2011..We assess the finite-sample properties of the proposed estimators against the estimators obtained from the existing methods. Data from a prevalent cohort study of patients with dementia are used to illustrate the proposed methodology...
Correlation between CpG methylation profiles and hormone receptor status in breast cancersWeiwei Feng
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Breast Cancer Res 9:R57. 2007..The present study was undertaken to determine whether methylation of a set of growth-suppressor genes would correlate to the expression of estrogen receptors (ERs) and progesterone receptors (PRs)...
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levelsSima Jeha
Department of Pediatrics, University of Texas, M.D. Anderson Cancer Center, P.O. Box 072, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Leuk Res 26:399-402. 2002..Unlike in adults, VEGF and VEGF-R2 levels in pediatric AML patients did not correlate with survival. This data suggest that the role of VEGF and its receptor VEGF-R2 in pediatrics AML may be different from that in adult AML...
Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumorsDarren W Davis
Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Clin Cancer Res 10:33-42. 2004..Endostatin's failure to induce high levels of TC death may explain its lack of significant clinical activity in this Phase I trial...
Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomyAshish M Kamat
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Urol 174:1262-5. 2005..In the absence of these criteria the incidence of ipsilateral positive margins is low. Thus, these criteria are valuable for predicting EPE and selecting patients for nerve sparing RP...
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor statusAbenaa M Brewster
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cancer 118:5637-43. 2012..The objective of this study was to evaluate the benefits of CPM using a propensity scoring approach that reduces selection bias from the nonrandom assignment of patients in observational studies...
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?Ricardo F Sanchez-Ortiz
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 101:2195-201. 2004..In determining whether it represents a metastasis, patients are frequently subjected to percutaneous renal biopsies. The authors evaluated their experience with this dilemma to formulate management guidelines...
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinomaPadmanee Sharma
Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 12:5442-7. 2006..These antigens were evaluated for both the degree of expression and prognostic value in cancer of the urothelium...
Detection of bladder cancer using a point-of-care proteomic assayH Barton Grossman
Department of Urology, M D Anderson Cancer Center, Houston, Tex 77030, USA
JAMA 293:810-6. 2005..Urine tests are frequently part of an evaluation, but have either been nonspecific for cancer or required specialized analysis at a laboratory...
Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experienceArlene O Siefker-Radtke
Center for Genitourinary Oncology and Department of Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
J Urol 171:145-8. 2004..The role of surgery for metastatic disease is not well established for urothelial cancer, but is sometimes undertaken in the face of persistent or recurrent disease that can be surgically resected...
Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgeryJeffrey M Albert
The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 30:2837-43. 2012..However, it is not known whether this recommendation should extend to other older women. Accordingly, we developed a nomogram to predict the likelihood of long-term breast preservation with and without RT...
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarrayLoleta D Harris
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Mol Carcinog 47:678-85. 2008..Although the expression of these genes correlated with factors known to be associated with patient outcome, none of them was an independent predictor of progression-free or overall survival...
Imputation for semiparametric transformation models with biased-sampling dataHao Liu
Division of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
Lifetime Data Anal 18:470-503. 2012..Simulation studies show that under small to moderate sample sizes, the proposed procedure has smaller mean square errors than two existing estimation procedures. Finally, we demonstrate the estimation procedure by a real data example...
Increased apoptosis in metastatic human colonic adenocarcinomasPaula M Termuhlen
Departments of Cancer Biology, Surgical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Cancer Biol Ther 1:58-63. 2002..Our data demonstrate that the molecular events associated with acquisition of the metastatic phenotype sensitize colon cancer cells to some pro-apoptotic stimuli...
Prostate cancer incidence in U.S. Air Force aviators compared with non-aviatorsDavid Rogers
MD Anderson Cancer Center, Houston, TX 77030, USA
Aviat Space Environ Med 82:1067-70. 2011..Instead, our study compared prostate cancer incidence rates among officer aviators and non-aviators in the U.S. Air Force (USAF) to reduce confounding by socioeconomic status and frequency of medical exams...
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Cancer 94:14-7. 2002..The mechanism underlying the association between high PE and poor clinical outcome is unclear, although it may be related to the possible PE reflection of tumor burden...
DNA methylation and environmental exposures in human hepatocellular carcinomaLanlan Shen
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA
J Natl Cancer Inst 94:755-61. 2002..6%; P<.001). CONCLUSION: Geographic variations in the methylation status of various CpG islands indicate that environmental factors may influence the frequent and concordant degree of hypermethylation in multiple genes in HCC tumors...
Marginal analysis of correlated failure time data with informative cluster sizesXiuyu J Cong
Department of Biometrics and Data Management, Boehringer Ingelheim Pharmaceuticals, P O Box 368, Ridgefield, Connecticut 06877, USA
Biometrics 63:663-72. 2007..We conduct simulation studies to assess and compare the finite-sample behaviors of the estimators and apply the proposed methods to a dental study as an illustration...
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trialsYi Cheng
Department of Mathematical Sciences, Indiana University at South Bend, South Bend, Indiana 46634, USA
Biometrics 60:910-8. 2004..Extensive simulation studies show that the exact confidence intervals have accurate nominal probability of coverage, and the proposed point estimates are nearly unbiased with practical sample sizes...
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapyJoel W Slaton
Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030USA
J Urol 171:570-4. 2004..Thus, in our view there is a compelling rationale to target these aspects of the malignant phenotype in this patient population...
Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and TherapeuticsYu Shen
Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA
IDrugs 10:848-50. 2007
[Diagnosis and treatment of urachal remnants with heterotopia sinus: a report of 2 cases]Xuan-Wen Zhu
Department of Urology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China
Zhonghua Nan Ke Xue 11:142-4. 2005..Surgical treatment should include radical removal of the urachus and the abnormal tissues associated with it...
Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivoLeiming Li
Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, USA
Cancer Res 65:7249-58. 2005..In addition to broad implications on in vivo validation of cancer targets, results from this study will also be instructive for practical applications of HIF-1-based cancer therapeutics...
Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activityYong Huang
Shanghai Institute of Materia Media, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, Shanghai 201203, China
Acta Pharmacol Sin 26:1243-7. 2005..CONCLUSION: Droloxifene has an anti-implantation effect in rats, and the effect appears to be not completely due to its anti-estrogenic activity...
Development of a tightly regulated U6 promoter for shRNA expressionXiaoyu Lin
Cancer Research, Global Pharmaceutical Research and Development, AP10/L01, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA
FEBS Lett 577:376-80. 2004..As a consequence of its tighter regulation, the 2O2 system greatly improved the success rate in making inducible knockdown cell lines...
Generation of cloned goats (Capra hircus) from transfected foetal fibroblast cells, the effect of donor cell cycleXiangang Zou
The Babraham Institute, Babraham, Cambridge, United Kingdom
Mol Reprod Dev 61:164-72. 2002..This study demonstrates that a foreign gene, such as the neo-resistant gene, can be introduced into goat foetal fibroblast cells, and that the resulting transgenic cells are capable of being cloned to produce 100% transgenic animals...
Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivoLeiming Li
Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, USA
Clin Cancer Res 12:4747-54. 2006..In addition, our results also show that the RNA interference-based inducible knockdown model can be a valuable platform for further evaluation of the combination treatment of other cancer therapeutics with HIF-1 inhibition...
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndromeBarry D Hock
Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand
Cancer 98:1681-8. 2003..Levels of the soluble form of CD86 (sCD86) are elevated in a proportion of patients with leukemia. Although it is a potential modulator of antitumor responses, the significance of sCD86 in patients with hematologic malignancies is unknown...
Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow upSeiji Suzuki
Departments of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
J Gastroenterol Hepatol 18:1364-72. 2003..The authors propose that the status of LOH in chronic hepatitis and liver cirrhosis patients before IFN therapy could be a potential predictor for the development of HCC...
Advances in the development of siRNA-based therapeutics for cancerYu Shen
Sirna Therapeutics, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60031, USA
IDrugs 11:572-8. 2008..An unbiased, independent evaluation of various tumor-delivery approaches will be a critical starting point in identifying the most promising delivery platforms for the development of siRNA-based cancer therapeutics...
Transition to burst synchronization in coupled neuron networksYu Shen
Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui, 230026, People s Republic of China
Phys Rev E Stat Nonlin Soft Matter Phys 77:031920. 2008..A reasonable mechanism behind such phenomena is given by using local mean field approximation, and the role of network topology is also discussed. The case when the neurons are coupled via chemical synapses is also briefly discussed...
Defining the optimal parameters for hairpin-based knockdown constructsLeiming Li
Cancer Research, Global Pharmaceutical Research and Development, AP10, Abbott Laboratories, Abbott Park, Illinois 60064, USA
RNA 13:1765-74. 2007..Based on the characteristic nucleotide preferences in the functional versus the nonfunctional shRNAs, we developed a computer program that outperforms an advanced siRNA selection algorithm for the enrichment of highly functional shRNAs...
A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulationXiaoyu Lin
Cancer Research and Advanced Technology, Global Pharmaceutical Research and Development, AP10, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA
Proc Natl Acad Sci U S A 105:174-9. 2008..These results also suggest that targeting mitochondrial ROS production might be a highly effective way of blocking HIF-1 activity in tumors...
[Discussion of naive Bayesian algorithm in prognosis prediction of primary liver cancer]Yu Shen
Dept. of Bio-Medical Engineering, Shanghai Jiaotong University, Shanghai, China
Space Med Med Eng (Beijing) 17:350-4. 2004..Successful application of the naive Bayesian algorithm in prognostic problem of primary liver cancer indicates a bright future of this method in medical field...
Research Grants
- STATISTICAL METHODS FOR BREAST CANCER SCREENING STUDIESYu Shen; Fiscal Year: 2007..abstract_text> ..
- STATISTICAL METHODS FOR BREAST CANCER SCREENING STUDIESYu Shen; Fiscal Year: 2003..In summary, the proposed research has the potential to increase the efficiency and reduce the cost of future periodic screening trials. ..
- Statistical Methods for Breast Cancer Prevention and Treatment StudiesYu Shen; Fiscal Year: 2010..With the proposed analytic methods, the improved estimations of screening benefit and treatment intervention will better inform health policy and clinical practice in breast cancer prevention and treatment. ..
